论文部分内容阅读
【目的】探究参松养心胶囊治疗急性冠状动脉综合征（ACS ）合并心律失常患者的临床疗效。【方法】选择本院就诊的72例ACS合并心律失常患者，随机将其分为对照组与观察组，每组36例。对照组给予常规治疗，观察组在此基础上加用参松养心胶囊。观察检测两组患者治疗总有效率、血流动力学、血液流变学及相关炎症因子水平。【结果】观察组治疗总有效率为97．22％，高于对照组患者的66．67％，其差异具有统计学意义（ P＜0．01）。治疗后，观察组血流动力学参数、血液流变学各指标及炎症因子水平均低于对照组患者，差异均具有统计学意义（均 P ＜0．05）。【结论】参松养心胶囊能够降低ACS合并心律失常患者体内炎症因子水平，改善患者血流动力学及血液流变学指标，其治疗效果明显，值得临床推广使用。“,”[Objective]To explore the efficacy of Shensongyangxin capsules on acute coronary hemodynam‐ics in patients with arrhythmia complicated syndrome .[Methods] A total of 72 cases of arrhythmias at our hospital in patients with acute coronary syndrome (ACS) ,36 cases in each group were randomly divided into control and observation groups .The control group received conventional treatment ,on the basis of observation group plus Shensongyangxin capsules .[Results]For observation group ,the overall effective rate was 97 .22%versus 66 .67% in control group .The difference was statistically significant (χ2 =11 .359 ,P <0 .01) .After treatment ,systolic blood pressure ,diastolic blood pressure ,mean arterial pressure and heart rate in observa‐tion group were lower than those in control group .And the differences were statistically significant ( P <0 .01) .After treatment ,hemodynamic indices were lower in observation group than those in control group . And the differences were statistically significant ( P<0 .01) .After treatment ,all indices of inflammatory cy‐tokines were lower in observation group than those in control group .And the differences were statistically sig‐nificant ( P <0 .01) .[Conclusion]Using Shensongyangxin capsules can enhance body immunity ,inhibit in vi‐vo inflammatory response and improve hemodynamics in ACS patients with arrhythmia .